Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Diagnostic Device Provides Wireless Remote Patient ECG Monitoring

By HospiMedica International staff writers
Posted on 16 Feb 2010
A hand-held patient-activated device wirelessly records and transmits reconstructed 12-lead electrocardiograms (ECGs), acquired via fully integrated electrodes and proprietary signal processing algorithms.

The CardioBip wireless remote patient monitoring device is a unique, hand held device that offers a solution to the problem of urgent ECG telemonitoring, capable of providing comprehensive and accurate ECG data, which is transmitted wirelessly. More...
The CardioBip device employs only three integrated electrodes, with the ability to generate a standard 12 lead ECG recording. Recordings are made by holding the instrument against the patient's chest, similar to single lead devices. The data collected provides sufficient information to allow accurate, immediate reconstruction of a complete 12-lead ECG from a calibrated, patient-specific transformation matrix. Additionally, the absence of any cables and the integrated nature of its electrodes offer the potential for fast networking with most hand held personal digital assistant (PDA) platforms.

The CardioBip-transmitted data may also be analyzed with Visual3Dx, a proprietary set of algorithms and tools that provide a method of generating a 3D representation of cardiac electrical activity as a function of time, superimposing the diagnostically relevant electrical information on an intuitive, revolving 3D anatomic model of the heart. Visual3Dx includes algorithms to normalize electrical attenuation, which results in a "virtual sphere" of normalized electrical activity, ensuring accurate and balanced representation of all heart regions. Visual3Dx also displays the standard ECG along with the 3D analytical presentation, which allows the physician to make correlations between both displays. The CardioBip device and Visual3Dx software are products of NewCardio (Santa Clara, CA, USA).

"NewCardio is committed to bringing significant value to each of the more than a quarter billion ECGs performed annually,” said Dr. Branislav Vajdic, CEO of NewCardio. "Our platform technology supports a wide-range of applications, and we are increasingly proud and excited about CardioBip's potential role in remote wireless monitoring of millions of patients with heart disease.”

Related Links:

NewCardio




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.